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Abstract
CRISPR-Cas is a genetic adaptive immune system unique to prokaryotic cells used
to combat phage and plasmid threats. The host cell adapts by incorporating DNA
sequences from invading phages or plasmids into its CRISPR locus as spacers. These
spacers are expressed as mobile surveillance RNAs that direct CRISPR-associated
(Cas) proteins to protect against subsequent attack by the same phages or plasmids.
The threat from mobile genetic elements inevitably shapes the CRISPR loci of archaea
and bacteria, and simultaneously the CRISPR-Cas immune system drives evolution of
these invaders. Here we highlight our recent work, as well as that of others, that seeks
to understand phage mechanisms of CRISPR-Cas evasion and conditions for population
coexistence of phages with CRISPR-protected prokaryotes.
1 Introduction
Uncovering the structure, function, and potential applications of the prokaryotic CRISPR-
Cas locus has been a growing research interest over the past 30 years [1]. These loci contain
a special family of clustered regularly interspaced short palindromic repeats (CRISPR)
and a unique group of CRISPR associated (Cas) proteins encoded by cas genes. The 30-
bp intervening sequences called ‘spacers’ are of extrachromosomal origin and correspond
to bacteriophage and plasmid genes, many of which are essential to infection or plasmid
transference [2, 3]. Early discoveries from genomic sequence analyses, including the negative
correlation found between the number of CRISPR spacers in Streptococcus thermophilus and
the strain’s sensitivity to phage infection [4] and the lack of CRISPR loci in unthreatened
laboratory strains, led researchers to postulate that these elements constituted a genetic
adaptive im mune system shaped by the host’s immediate environment [5]. Soon after,
CRISPR-mediated phage resistance by the integration of spacers, as well as the loss of resis-
tance following the deletion of these crucial spacers, was experimentally demonstrated [6, 7].
Though there is a vast variety of these systems [8], the general mechanisms of CRISPR-
Cas can be divided into three stages of adaptation, expression, and interference, as seen in
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Figure 1. Biochemical and structural analyses have investigated the molecular mechanisms
and conformational changes of the Cas proteins associated with each of these stages [9]. The
host cell combats phage and plasmid threats in its environment by encoding spacers into
its genome from one or multiple DNA sequences of previous invaders, called protospacers.
New spacers are incorporated directly downstream of an AT-rich ‘leader’ sequence, which
characteristically flanks the start of the locus, and older spacers may be deleted at random.
The sequential ordering of spacer acquisition provides chronological information about the
order in which a cell encountered each phage or plasmid. Each spacer is then expressed as
a mobile surveillance CRISPR RNA (guide crR NA) that contains a single spacer and a
partial repeat sequence on one or both sides. In some CRISRP types, an additional trans-
activating CRISPR RNA (tracrRNA) is needed to anchor the crRNA to the Cas surveillance
protein. The guide crRNA directs these Cas proteins to interfere with subsequent threats
by targeting and specifically cleaving the invading DNA sequences, or in less common cases
RNA sequences, that match those of the spacers. Specificity requirements for the recognition
of targets vary among CRISPRs. Some require a perfect match between the guide crRNA
and the target DNA sequences, while others can tolerate a certain number of mismatches
if, for example, the invader has undergone a point mutation. CRISPR-Cas systems that
utilize a protospacer adjacent motif (PAM) to distinguish between self and target genomes
generally cannot tolerate mutations in this motif region [10].
Most of the archaea and about half of the bacteria that have been sequenced contain
functioning CRISPR-Cas systems. An evolving CRISPR-Cas classification system [8] cur-
rently organizes these systems into two overarching classes, for those that utilize a single
interference protein versus those that use multiple Cas protein units to survey and cut the
target. The systems are further delineated into six major types based on their principle cas
gene and more than 16 subtypes defined by their Cas protein content. A single organism
could have multiple types of CRISPR loci. Additionally, there are still a number of rare,
unclassified systems. Figure 2 shows a representative example of the Cas protein content
within the Type I CRISPR.
An extensive genomic analysis of the CRISPR repeats, spacers, leader sequences, and
cas genes in lactic acid bacteria genomes revealed the likelihood of CRISPR locus acquisi-
tion through horizontal gene transfer (HGT) between distant organisms [12]. Interestingly,
further HGT in a CRISPR-Cas-protected genome appears to be blocked, explaining the lack
of loci in antibiotic resistant and lysogenic bacteria [13]. Due to the polarized spacer acqui-
sition that causes the ancestral end to contain phylogenetic anchors and the active end to
contain recent encounters, the locus can be used to reconstruct the history of strain diver-
gence [14]. Additionally, CRISPR immunity has been shown to facilitate speciation within
the Streptococcus, Staphylococcus, Lactobacillus, and Bifidobacterium genera [14]. The loss of
CRISPR-Cas in some strains within a given species allows those strains to acquire virulence
via HGT, eventually leading t o the emergence of a new pathogenic species.
In exploring how CRISPR-Cas systems could be manipulated, a locus was transferred
from one organism into a distantly related one to confer protection against specific plas-
mids and phage infections [15]. One of the more drastic transfers was an oral bacterium’s
RNA-targeting Type VI-A system that was successfully introduced into Escherichia coli,
which naturally contains DNA-targeting CRISPRs, to defend the cell from an RNA bacte-
riophage [16]. Following this initial success, immunization of dairy industry-relevant prokary-
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Figure 1: The prokaryotic CRISPR-Cas defense cycles through three stages of adaptation,
expression, and interference that are mediated by Cas proteins unique to the CRISPR locus
(see also Figure 2). (A) During adaptation, the CRISPR-Cas system incorporates proto-
spacer sequences from previous invaders into its locus as spacers. A new repeat is copied as
the spacer is inserted directly downstream from the leader sequence. (B) During expression,
a crRNA guide is created. Depending on the type of CRISPR system, the crRNA is anchored
either to one Cas protein or to a multi-component Cas protein complex. During interference,
the Cas protein(s) surveil mobile genetic elements that enter the cell and specifically cut se-
quences that match the crRNA to inhibit infection and replication. There is experimental
evidence of both DNA and RNA targeting, depending on the type of CRISPR-Cas system.
Reprinted with permission from [11].
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Figure 2: Each CRISPR-Cas system has a diverse set of Cas protein machinery. For
example, in the Class 1, Type I systems, Cas1, Cas2, and Cas4 are used to acquire spacers;
Cas6 processes these spacers into crRNA; a complex of multiple Cas protein subunits is used
to surveil the target sequence; and Cas3 is recruited for target cleavage. The seven subtypes
for Type I are I-A, I-B, I-C, I-D, I-E, I-F, and I-U. See Makarova et al., 2015, for the complete
Cas protein content of other CRISPR systems [8].
otes was carried out to establish resistance to anticipated phage attacks [17, 18]. A turning
point came in the applications side of the field when researchers realized the possibility of
harnessing the CRISPR-Cas system to make specific genomic modifications in both prokary-
otic and eukaryotic cells [9, 19]. The Cas9 protein from Type II systems can be re-programed
with a single, custom guide sequence to make specific genomic cut s for sequence insertions
or deletions. Catalytically deactivated Cas9 (dCas9) can furthermore be fused to a pro-
moter or represser to respectively activate (CRISPRa) or interfere (CRISPRi) with targeted
genes [20] and facilitate epigenetic studies [21].
The coevolution of CRISPR-Cas-containing bacteria with plasmids and virulent phages
creates what many call a coevolutionary “arms race.” Mathematical models that have been
developed to investigate this coevolution either take a mean field approach to model the
rate of change of population abundances, usually of wild-type and mutant phages and sen-
sitive and immune bacteria, or look on a more detailed level at phage and bacterial strains
represented as arrays of protospacers and spacers. Generally, the degree of immunity, her-
itability, and benefit of maintaining the CRISPR-Cas system are studied as functions of
the number and content of spacers, the abundance and diversity of phages and hosts, and
CRISPR-associated fitness costs, such as autoimmunity and the restriction of HGT. Koonin
and Wolf, 2015, provides a detailed review of phage-host evolution models [22]. While the
threat from mobile genetic elements inevitably shapes the CRISPR loci of archaea and bac-
teria, i t is equally interesting to focus on the evolution of these invaders as they respond
to the CRISPR-Cas system. Here we highlight our recent work, as well as that of others,
that seeks to understand phage mechanisms of CRISPR-Cas evasion and conditions for pop-
ulation coexistence of phages with CRISPR-protected prokaryotes. We begin with a look
at the nature of the host cell’s defense that puts pressure on phages to diversify. Then, we
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describe the theoretical conditions and advantages of phage protospacer evolution, followed
by experimental observations of this as well as observations of novel phage counterattack
mechanisms. We end with a couple of representative clever applications that utilize the
phage-CRISPR host interaction.
2 Targeting of phages by CRISPR
2.1 CRISPR spacer content
The CRISPR spacer content provides a record of the phages to which bacteria have been
exposed, as viewed through the lens of selection. Experiments with S. thermophilus [23]
and Leptospirillum [24] have shown that the diversity of CRISPR spacers in a population of
bacteria decreases with distance from the leader. Many subsequent studies confirmed these
initial observations. However, some studies showed a more uniform dependence of diversity
with distance from the leader.
In one of the first theoretical studies of the CRISPR system, we sought to explain these
observations using a population dynamics model [25]. Each bacterium had a CRISPR locus
of a finite length, with the oldest spacer dropped when the number of spacers exceeded 30
per locus. The CRISPR locus was copied to daughter cells after bacterial division. We found
that the diversity of the spacers decreased with distance from the leader. Spacers leading to
resistance against the dominant phage were especially selected for and accumulated in the
CRISPR array.
In a second model, we sought to explain the time dependence of this decay of diversity
with distance from the leader [26]. Again, we found that spacer diversity decreased towards
the leader-distal end due to selection pressure on shorter timescales, as shown in Figure 3. On
longer timescales, we found that spacer diversity was nearly constant with distance from the
leader. Thus, spacer diversity decays more rapidly when bacteria are exposed to new phages,
either through bacterial migration or phage influx. These results offer one explanation for
the two differing experimental observations of spacer diversity.
2.2 Gain or loss of immunity
Immunity to phages that CRISPR confers upon bacteria is not perpetual. Changes in
the phage population lead to abrogation of the protection afforded by the CRISPR spacers.
Defining the spacer effectiveness as the match between a spacer and the phage strains present
in a population, we found that spacer effectiveness decreases towards the leader-distal end
as well [26].
While the mechanism by which protospacers from the phages are inserted as spacers
into the bacterial CRISPR array adjacent to the leader is known, the mechanism by which
spacers are deleted is less clear. We investigated whether the results for spacer diversity and
immunity were persistent with changes to the mechanism of spacer deletion [26]. The results
for spacer diversity and immunity were relatively insensitive to whether the oldest spacer was
deleted, one of the older spacers was deleted with increasing probability toward the leader-
distal end, or a random spacer was deleted from anywhere in the locus. This insensitivity to
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Figure 3: Theoretical results for the diversity of spacers in the CRISPR locus as a function
of distance from the leader sequence. The leader-proximal spacers are more diverse than
the leader-distal spacers as the CRISPR samples a new environment. After a long time in
a stable environment, the diversity of spacers becomes constant along the locus, a function
of the relatively constant diversity of phages in the environment. Reprinted with permission
from [26].
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deletion mechanism results because selection provides a strong bias for successful deletion of
the old spacers that no longer match actively infecting phage.
Loss of immunity can lead to oscillations in the population size of bacteria and phage.
This phenomenon was investigated in a minimal, Lotka-Volterra type predator-prey model of
a host with a heritable, adaptable immune system, e.g., a CRISPR-Cas system [27]. When
the immunity decay rate is larger than the immunity acquisition rate, periodic oscillations
of the populations of immune hosts, sensitive hosts, and phages become larger and lead to
quasi-chaotic behavior. A similar behavior is also observed for the case in which the immunity
acquisition rate is greater than the immunity decay rate, however the fraction of immune
hosts is larger here. There were critical values of the phage reproduction rate separating the
phases of stable equilibria, small periodic oscillations, and quasi-chaotic oscillations.
When the rate of spacer deletion is small, the phase diagram no longer follows the pre-
dictions of the classical mean-field, predator-prey model. The phage extinction probabil-
ity during exposure to CRISPR-bearing bacteria becomes non-classical and reentrant [28].
Parameters affecting the phase diagram include rates of CRISPR acquisition and spacer
deletion, rates of phage mutation and recombination, bacterial exposure rate, and multiple
phage protospacers. The new, non-classical region appeared at a low rate of spacer deletion,
as seen in Figure 4. The population of phages progressed through three extinction phases
and two abundance phases, as a function of bacterial exposure rate.
2.3 CRISPR locus length and phage diversity
The number of spacers in the CRISPR locus and the phage diversity are critical param-
eters affecting the bacteria and phage coevolution. In [29], a well-defined, simple system
was studied experimentally. Bacteria immune to a single type of phage via a single spacer
were observed to be eventually invaded by phages. The single spacer caused incomplete
resistance because of a high rate of CRISPR escape mutations. That is, the bacteria were
invaded by phages that had made single mutations in their protospacer regions. Conversely,
the CRISPR-Cas efficacy is predicted to increase rapidly with number of protospacers per
phage genome [30].
Aspects of the complex phage-bacteria coevolution were also studied theoretically. Pro-
tection and immunity can be non-monotonic in time because of the decreasing phage popu-
lation diversity over time [26]. A stochastic, agent-based mathematical model of coevolution
of host and phage shows CRISPR-Cas efficacy is dependent on population size, spacer in-
corporation efficiency, number of protospacers per phage, phage mutation rate, and fitness
cost of maintaining a CRISPR-Cas system [30]. The coevolution of the CRISPR-Cas im-
mune system and lytic phages was modeled under evolutionary and ecological conditions,
i.e., coupling of host and phage reproduction and death rates, in which CRISPR-Cas immu-
nity stabilizes phage-host coexistence, rather than extinction of phage. The overall phage
diversity was observed to grow due to an increase of host and phage population size, not
specifically due to CRISPR-Cas selection pressure on single protospacers. The CRISPR-Cas
system was predicted to become ineffective at a certain phage diversity threshold and lost
due to the associated fitness cost of maintaining cas genes.
Another model similarly showed the evolved average number of spacers in the CRISPR
depended on the phage mutation rate and the spacer cost to fitness [31]. At low mutation
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Figure 4: The nonclassical phase diagrams of (a) the phage extinction rate and (b) the
bacterial extinction rate resulting from a coevolutionary model. These complex patterns
of phage-bacteria coexistence represent the delicate balance in place among the bacterial
exposure rate, phage evasion through mutation, number of available protospacers, and rate
of spacer acquisition. (c) A small rate of CRISPR spacer deletion leads to the three observed
phases of phage extinction and two phases of phage survival that depend on the rate of
bacterial exposure. Reprinted with permission from [28].
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Figure 5: A mathematical model of how the length and prevalence of the CRISPR array
depend on the phage (viral) mutation rate. With low phage mutation rates, CRISPR-Cas
systems are highly prevalent and select to retain low numbers of spacers to match the low
diversity of phages. As the phage mutation rate increases, CRISPR-Cas systems become
less frequent, though those that are present are collecting more spacers to keep up with the
diversifying phage population. At a certain phage mutation threshold, the CRISPR locus
becomes too long to be effectively maintained and is rapidly lost from the host population.
Reprinted with permission from [31].
rates, a limited number of spacers was sufficient to confer protection to the bacteria against
the phage population of limited diversity, shown in Figure 5. As the phage mutation rate
increased, the CRISPR loci increased in length. At a critical threshold of phage mutation,
the CRISPR array became unable to recognize the diverse phage population, and the average
locus length fell rapidly to zero, even if the rate of spacer addition outpaced phage mutation
rate. It was speculated that similar behavior would occur from an increasing immigration
rate of new phages.
One hypothesis for the greater fraction of hyperthermophiles that have effective CRISPR-
Cas systems compared to mesophiles is that the lower rates of mutation and fixation in
thermal habitats lead to more effective, and therefore selected for, CRISPR systems in ther-
mophiles. Additionally, another possible mechanism suggested theoretically is that CRISPR
becomes ineffective in mesophiles because of larger population sizes [30].
3 Selection for mutation and recombination in the phage
The bacterial immune system of CRISPR implies a selective advantage for those phage
with mutations in the PAM or protospacer regions. That is, a mismatch between the crRNA
sequence and PAM or protospacer of invading phage is likely to allow the phage to infect
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and replicate in the bacteria. Concomitantly, the mechanism of recombination can integrate
multiple point mutations, increasing the chance of a mismatch that would allow the phage
to escape CRISPR recognition. In this setting, recombination can be a positive mechanism
for generating genomic diversity.
3.1 Coevolutionary implications
A number of coevolutionary dynamics models have captured the idea that not only can
phages evade CRISPR-Cas via mutation or recombination of protospacers, but also bacteria
can regain immunity through acquiring more spacers from the same phage. These models
are reviewed in [22]. In our own work, we first considered CRISPR arrays with between two
and 30 spacers, considering the possibility of phage mutation. These refinements supported
the main prediction that the diversity of spacers was found to decrease with position from
the leader proximal end [25].
A combination of mathematical models, population dynamic experiments, and DNA
sequence analyses have been used to understand CRISPR-containing-host and phage co-
evolutionary dynamics in the S. thermophilus CRISPR-Cas and virulent phage 2972 model
systems [29]. There was a particular interest in hosts that had gained resistance by the
addition of novel spacers and phages that evaded resistance by mutation in their matching
sequences. The coevolution between the phage and bacteria was termed an “arms race,”
perpetuated by the competing effects of spacer acquisition and protospacer mutation.
The effects of recombination depend on the degree of divergence between protospacer
and spacer required for the phage to escape CRISPR surveillance. We showed there is little
difference between the results from point mutation and those from recombination in the
phage genome if the phage needs just one mismatch to escape [26]. However, when the
phage needs two mismatches to escape, the difference is apparent in the immunity, the rate
at which bacteria are able to kill phages. Recombination, by combining mutations, is a
more rapid generator of protospacer diversity and is a more successful phage escape strat-
egy when CRISPR has a higher mismatch tolerance with the protospacers, see Figure 6.
When the phage has multiple protospacers, a similar argument implies that recombination,
now of the protospacers rather than of genetic material within a single protospacer, again
leads to a more rapid escape of the phage than does point mutation alone. This result
occurs because mutation in different protospacers can be recombined, making it substan-
tially less likely for the CRISPR to recognize the recombined daughter phage. Thus, the
phage recombination-mediated escape mechanism is also more successful when the phage
has multiple protospacers. The immunity afforded by CRISPR is lower as mutation and
recombination rates increase.
The interplay between the CRISPR pressure on the phage and the phage pressure on the
bacteria leads to a phase diagram of coexistence. That is, only in some parameter regions
do the phages and bacteria coexist. The pattern of coexistence is more complicated than the
classical predator-prey model, due to the feedback of the CRISPR system on the phage. A
low phage mutation rate can lead to a phage extinction probability that is a non-monotonic
function of bacterial exposure rate [28]. The resulting nonclassical phase diagram in Figure 4
shows the extinction and abundance tipping points that result from a complex relationship
between the bacterial exposure rate and the phage mutation rates.
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Figure 6: A mathematical model shows that bacterial CRISPR immunity decreases with
increasing phage mutation or recombination rate. When the bacteria’s CRISPR-Cas system
has a mismatch tolerance of just one nucleotide, there is little difference between the effect
of phage mutation and recombination (left). However, when there is a higher mismatch
tolerance of two nucleotides, recombination gives the phage a higher probability to survive
(right). Reprinted with permission from [26].
3.2 Constraints on non-synonymous mutations
One important difference between thermophiles, with habitats of 42−122◦C, and mesophiles,
with habitats of 20− 45◦C, is that protein stability is a more crucial factor in thermophiles.
That is, mutations are more likely to be deleterious in thermophiles, because on average
proteins are more easily destabilized by mutation at higher temperatures [32]. A stochastic
model of phage-CRISPR coevolution was used to investigate why CRISPR-Cas systems are
more prevalent in thermophiles than mesophiles [31]. Mutations are more likely to be lethal
in thermophilic environments because high temperatures reduce protein stability, therefore
there is selection for phages that mutate less. It was argued that the reason roughly 90%
of archaea, which are mostly thermophiles, have CRISPR-Cas systems is because they work
well in this habitat. Further support for this hypothesis was that the CRISPR-Cas is more
correlated with thermophilic environments than with archaeal taxonomy. This stability cri-
terion was used to compute a phage mutation rate threshold, beyond which phage were
selected against.
3.3 Benefits of CRISPR vs other immune mechanisms
Bacteria have other, innate mechanisms of resistance against phages. For example, the
bacterial surface receptors that promote phage attachment and entry can undergo modifica-
tion. A model was used to study the evolution of CRISPR-Cas positive and negative hosts
as they encountered phages [31]. The interaction events were either successful microbial
protection against infection or successful phage infection. The CRISPR-Cas positive host
could delete or lose the CRISPR system and the CRISPR-Cas negative host could acquire
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a CRISPR system by HGT. The fitness of the phages increased by productively infecting
hosts and creating phage progeny, whereas the fitness of the hosts increased by acquiring
CRISPR-Cas and useful spacers. There was a potential fitness cost to the hosts due to au-
toimmunity of the CRISPR system inhibiting normal bacterial gene function and restriction
of potentially beneficial HGT events. The CRISPR-Cas system was found to be beneficial at
intermediate levels of the innate resistance. There was little fitness advantage from CRISPR
storing spacers of phages that the bacteria were unlikely to encounter again. When the bac-
teria survived two-thirds of its phage encounters without the help of CRISPR, maintaining
the CRISPR system was too costly, i.e., there was no benefit to having it.
3.4 Heterogeneous environments
Many of the models of the CRISPR system assume a mean-field, homogeneous distri-
bution of the phage and bacteria in space. Spatial effects and heterogenous environments,
however, occur in the body and in nature, and these effects can have a significant effect on
the outcome. Indeed, experiments carried out with S. thermophilus and phage 2972 have
shown that a small percentage of acquired spacers matched the closely related phage 2766
that had migrated spatially [33]. A mathematical model of bacteria-phage coexistence was
used to take into account the effects of space on species coexistence and adaptive CRISPR
defense [34]. In the model, bacteria and phage populations spread on a two-dimensional
square. Parameters of the model included the effective infection rate of microcolony of bac-
teria, i.e., the probability of infection, and the mean latency time, as a ratio of phage to
bacteria mean replication. Two spatial arrangements of phage replication were explored: a
well-mixed system, in which phage offspring were placed at random sites, and a slow diffu-
sion model, in which phages only spread to neighboring sites. Bacteria dynamically acquired
resistance through CRISPR-Cas to the diverse phage population while removing the oldest
spacers. For successful phage survival, i.e., not leading to depletion of bacterial hosts or
exceeding available spatial carrying capacity, a balance was needed between the effective
infection and phage replication rates. At least two phage strains were needed to allow sta-
ble coexistence with bacteria. Coexistence persisted as long as the maximum number of
CRISPR insertions was fewer than the total number of phage types.
Another strain-level model of the origin and diversification of CRISPR arrays in host and
protospacers in phages was developed, taking density-dependent ecological dynamics into
account [35]. To understand the coevolution of strain diversities as well as densities, three
main components in the model were specified: coupling among host and phage reproduction
and death rates, molecular scale CRISPR events based on sequence matches between spacers
and protospacers, and evolutionary changes of phage protospacer mutation and CRISPR
spacer acquisition. A maintenance of many coexisting strains in highly diverse communities
was observed, with high strain similarity on short timescales but high dissimilarity over
long timescales. Short term changes in host diversity were driven by incomplete sweeps
of newly-evolved high-fitness strains in low abundance, recurrence of ancestral strains that
gained fitness advantage in low abundance, and invasions of multiple dominant coalitions
that arose from having nearly identical immune phenotypes, but different genotypes, i.e.,
similar protection afforded by the incorporation of different protospacers. A majority of new
phage mutants did not have a significant increase in fitness, since mutation was random. In
12
this model only the first spacers were important to shaping selective coevolution because
they provided the highest immunity, and the predicted spacer acquisition rate was more
important to diversification than was CRISPR immunity failure.
4 Experimental evidence for phage evasion of CRISPR
4.1 Synonymous mutations
The evasion of CRISPR-Cas by phage evolution has been explored in a number of stud-
ies. The CRISPR-Cas system creates an evolutionary battle between phage and bacteria
through addition or deletion of spacers in the bacteria and mutations or deletions in the
phage genomes, as reviewed in [36]. There is evidence for phage evasion: a small popula-
tion of virulent phage mutants was observed to infect previously bacteriophage-insensitive
bacteria. These infecting phages had single nucleotide changes or deletions within their tar-
geted protospacer. Indeed, the CRISPR locus is subject to dynamic and rapid evolutionary
changes driven by phage exposure, and therefore CRISPR spacers can be used to analyze
past host-phage interactions.
A study of the lactic acid bacteria S. thermophilus and the role of its CRISPR1 locus in
phage-host interactions was carried out by selecting two different bacteriophage-insensitive
strains and exposing them to other phages to which they were sensitive [23]. The addition
of one new spacer of about 30 nucleotides in CRISPR1 was the most frequent outcome of
a phage challenge. Spacers were only acquired from protospacers with an AGAAW motif 2
nucleotides downstream from the protospacer. There was also evidence of spacer deletion.
Successive phage challenges and subsequent addition of spacers increased the overall resis-
tance of the host to the phage. Newly added spacers were required to be identical to the
protospacer region in the phage genome to confer resistance to phage. Indeed, phages were
able to evade CRISPR immunity through single nucleotide mutations and deletions. The
most common mechanism of escape was mutation within the protospacers or AGAA flanking
sequences.
Natural hot springs provide a rich source of microbial and phage diversity. A metagenomic
analysis of the Yellowstone hot springs to study natural evolution of microbial and phage
populations due to the CRISPR immune system was carried out [37]. Two thermophilic
Synechococcus bacteria isolates were sequenced from microbial mats in the Octopus and
Mushroom springs in Yellowstone National Park, Syn OS-A from high temperature areas
and Syn OS-B’ from low temperature areas, to make comparisons with phage and prokary-
otic metagenomic data collected from the same springs. The Syn OS-B’ genome contained
individuals from two types of CRISPR loci, while Syn OS-A contained individuals from three
types, with these types distinguished by their repeat sequence. The Type III repeat sequence
identified in Syn OS-A, but not Syn OS-B’, was also present in another abundant microbe in
the mat, Roseiflexus RS-1, suggesting recent DNA transfer between them. While CRISPR
repeats were of course highly conserved within the microbial metagenome, spacer sequences
were quite unique, and from the CRISPR sequence data it was difficult to find matches to the
phage metagenomic data. Nonetheless, several spacers matched lysozyme and lysin protein
genes. Note that lysozyme enzymes attack the cell wall late in phage infection, causing cell
13
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Figure 7: CRISPR more effectively eradicates less diverse phage populations. Experimental
evidence of the ability of two phage types to coexist with CRISPR bacteria (right) for a
longer period of time than a single phage type could (left). The host cell population (CFU
per milliliter) is shown in blue, and phage counts (PFU per milliliter) are shown in red.
Reprinted with permission from [33].
lysis and release of phages. There were some silent or conservative mutations found in these
phage lysozyme or lysin protein sequences that did not affect protein function, but most
likely helped the phage to evade CRISPR identification.
4.2 Recombination
The phage genomic regions targeted by CRISPR are driven to have mutations [33]. Ho-
mologous recombination events between genetically related phages can then further diversify
the phage population. Long-term coevolution experimental studies were carried out with S.
thermophilus and phage 2972 for up to 232 days, until the phage went extinct. An anal-
ysis of the S. thermophilus spacers revealed that spacers acquired during the experiments
mapped unevenly over the phage genome. The immune pressure from CRISPR drove escape
mutations located exclusively in the protospacer and PAM regions, as well as the accumu-
lation of phage genome rearrangements. Phage mutation rates were much higher than that
of the bacterial host, and the presence of phages also accelerated host genome evolution in
the CRISPR array. The coexistence of multiple phages allowed recombination events that
boosted the observed substitution rates beyond the bare mutation rate, termed the “rescue”
effect, see Figure 7.
Experiments show that the most recently acquired spacers match coexisting phages [38].
In other words, the phage population evolves, abrogating the utility of old spacers. Phages
use extensive recombination to shuffle sequence motifs and evade the CRISPR spacers. Spac-
ers of CRISPR loci recovered from Leptospirillum group III, I-plasma, E-plasma, A-plasma,
and G-plasma microbial communities in biofilms collected from Richmond Mine (Redding,
CA) were used to link phages to their coexisting host bacteria and archaea. A majority
of spacers corresponded to phages, though some corresponded to other mobile genetic ele-
ments, such as plasmids and transposons. It was found that microbial cells targeted several
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different phage populations, and only a few CRISPR spacers were widely shared among
bacterial strains. For example, some E-plasma cells target specific AMDV2, AMDV3, and
AMDV4 phage variants, and some spacers match dominant phage sequence types. Yet many
spacers match sequences characteristic of only one or a small number of genotypes within
the population. The phage population is reshaped by extensive homologous recombination,
as evident from combinatorial mixtures of small sequence motifs. This recombination re-
sulted in genetic blocks shared by different phage individuals that were often no more than
25 nucleotides in length, creating new phage sequences that can disrupt the function of the
CRISPR’s 28 to 54-nucleotide spacers. A benefit of recombination is that if the preexisting
sequence diversity in the phage population is mainly in the protospacer and PAM regions,
recombination can increase this diversity in a combinatorial way without introducing novel
diversity outside these regions. In this fashion, recombination creates new DNA sequences
with a lower risk of altering protein function than does mutation and limits alterations to
the phage genome outside of the CRISPR-recognized PAMs and protospacers.
4.3 Mutations in PAM, seed, and non-seed regions are distinct
The original view that a single mutation in the protospacer region is sufficient to allow
phage to escape from CRISPR has transformed into a more nuanced view of CRISPR recog-
nition being quite sensitive to mutations in a seed region, which is usually defined as the
protospacer’s eight PAM-proximal nucleotides [9], but less sensitive to mutations in the rest
of the protospacer region. An experiment with a co-culture of S. thermophilus with phage
2972 for one week studied the impact of spacer acquisition and host population diversifica-
tion on phage genome evolution [39]. Tracking of CRISPR diversification and host-phage
coevolution revealed a strong selective advantage for phages containing PAM or near PAM
mutations. A genetically diverse bacterial population arose, with multiple subdominant
strain lineages. All surviving S. thermophilus cells had at least one newly incorporated
spacer against phage 2972. Of the two loci sequenced, CRISPR1 was the most active, and
CRISPR3 only incorporated single spacers. In this experiment, all recovered phages con-
tained a synonymous mutation eight nucleotides from the PAM, apparently leading to escape
from S. thermophilus spacer1 in the CRISPR1 loci. The fixation of this mutation suggests
that only phage that had it could rise in abundance. This phage sequence encodes a protein
that recognizes the host, and there is strong selective pressure for the host to abrogate this
recognition. Also in this experiment, 88% of recovered phage sequences contained synony-
mous mutations six nucleotides from PAM, likely leading to escape from spacer32. Finally,
92% of phage sequences contained non-synonymous mutations in the PAM corresponding to
spacer6. There were no observed phage mutations in the regions targeted by any CRISPR3
spacers.
4.4 Long-term study of heterogeneous environments
A long term metagenomic study of archaeal, bacteria, and phage populations in Lake
Tyrrell (LT) from 2007 to 2010 was carried out, and the dynamics of their populations on
timesscales of months to years was studied [40]. Samples were collected and analyzed from
LT over three summers and four winters. Overall, archaeal and bacterial populations were
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more stable than the phage populations, i.e., over the timescale of years, phage populations
were less stable than their prokaryotic prey. Analysis of CRISPR arrays indicated both rare
and abundant phages were targeted, suggesting archaeal hosts attempt to balance protecting
themselves against persistent, low-abundance phages and highly abundant phages that could
destroy the host community. There was a high diversity of phages in the environment, and
even in the absence of superinfection, the CRISPR array sampled extensively from this
diversity.
4.5 Plasmid evasion of CRISPR-Cas
While plasmids and phage bear a resemblance, interestingly the selection pressure on
plasmids from CRISPR appears somewhat different from that on the phage. Namely, the
rate of plasmid mutation is much slower than combined rate of loss of CRISPR immunity
by spontaneous mutation or deletion. On the one hand, plasmids can confer positive fea-
tures upon bacteria, such as antibiotic resistance. Analysis via experiments and computer
modeling of the loss of CRISPR-Cas loci in the presence of an environment containing plas-
mids that increase the host’s fitness has been carried out [41]. Conjugational transfer of the
Staphylococcal plasmid pG0400 (nickase gene nes) into Staphylococcus epidermidis, which
contained a spacer targeting this plasmid, was analyzed. Simulation results showed plasmid
transfer into the host could occur if the plasmid mutated, the CRISPR lost the associated
spacer, the CRISPR locus became deactivated or deleted, or the CRISPR response was
subdued. Experiments showed the wild-type plasmid on CRIPSR-negative mutants only,
meaning that instead of utilizing the phage mechanism of mutating their targeted regions
to evade CRISPR-Cas, a plasmid “evasion” strategy could occur within the host, i.e., loss
of CRISPR locus allowed the host to receive the beneficial plasmid. In vitro experiments
showed little to no intrinsic fitness cost of losing CRISPR.
5 Emergence of game theoretic strategies in the phage
5.1 Anti-CRISPR proteins
The phages evade CRISPR by more than just mutation and recombination. Phages have
evolved more complicated mechanisms that may be understood from a game theoretic point
of view. Anti-CRISPR proteins have been identified in phage that are associated with inacti-
vating Type I-E and I-F CRISPR-Cas systems [42]. These anti-CRISPR proteins, discovered
to be encoded by Pseudomonas aeruginosa phages, circumvent CRISPR by inactivating the
Cas proteins. Five distinct families of proteins that targeted Type I-F and four that tar-
geted Type I-E were found. The existence of subsets of these genes among phages suggests
HGT may have been responsible for a “mix and match” scenario of acquiring them. The
mechanisms of action of three unique I-F interference inhibitors, AcrF1, AcrF2, and AcrF3,
are illustrated in Figure 8. Briefly, in Type I-F CRISPR-Cas systems, a Csy complex is
guided by crRNA to bind to invading DNA, and Cas3 is recruited for target cleavage. AcrF1
binds along the full Csy3, which comprises three molecules in the Csy complex, but alloster-
ically interferes with DNA binding. AcrF2 binds to the Csy1-Csy2 heterodimer in the Csy
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Figure 8: Depiction of mechanisms used by three different anti-CRISPR proteins that
target the Type I-F CRISPR system, which contains a crRNA:Csy surveillance complex and
Cas3 cleavage protein. Anti-CRISPR proteins AcrF1 and AcrF2 attach directly to the the
Csy complex to block the crRNA from fully binding with the target DNA. Protein AcrF3
attaches to the Cas3 protein to prevent it from being recruited to cleave a bound target.
Reprinted with permission from [42].
complex to block the 5’ end of crRNA and directly prevents DNA binding. AcrF3 interacts
with Cas3 to block its recruitment to the Csy complex. These mechanisms could potentially
regulate lateral gene transfer to allow foreign DNA to bypass CRISPR-Cas inhibition. In a
separate experiment, it was also found that another phage produced enzymes upon infection
that induced a phenotypic phage resistance in sensitive bacteria, but killed bacteria with
CRISPR, even in the presence of many phages [29].
5.2 Phage encoding its own CRISPR
Amazingly, CRISPR elements have even been found in prophages and phage DNA seg-
ments. Whole-genome microarray analysis revealed that the Clostridium difficile genome
contained mobile genetic elements, such as prophages, which contained CRISPR loci [43].
The complete genome sequence was determined for strain 630 of C. difficile, which is virulent
and multidrug-resistant. An unusually large fraction of the genome, 11%, consists of mobile
genetic elements (MGEs), including two prophages and a prophage-like element, responsible
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for acquisition of genes involved in antimicrobial resistance and virulence. Ten CRISPR
DNA repeat regions were identified with no evidence of their expression or function. Inter-
estingly, several were located on the prophages and prophage-like element, suggesting the
phages had incorporated a CRISPR with spacers against other phages.
Twenty-two CRISPR arrays were found in the phage sequences from a metagenomic
study of the genetic composition of the phage population in the human gut microbiome [44].
Simultaneously isolated at two time points, one of the phage’s spacer sequences matched
the sequence of another phage present in the same individual, suggesting a phage-phage
competition mediated by CRISPR. Additionally, there was an array that showed greater
than 95% identity in the repeat regions to the previously found CRISPR in C. difficile [43],
described above.
One bacteriophage has been observed to directly combat a host bacteria’s immunity
by using a CRISPR-Cas system [45]. The bacterial Vibro cholerae serogroup O1, which
causes cholera, can be treated with the International Centre for Diarrhoeal Disease Re-
search, Bangladesh cholera phage 1 (ICphage1). The currently active V. cholerae strain “El
Tor” does not contain a CRISPR-Cas system, however it encodes an 18kb phage-inducible
chromosomal island-like element (PLE). The phage-inducible chromosomal island is a highly
mobile genetic element that contributes to HGT, host adaptation, and virulence, by using
phages as helpers to promote the host’s spread while simultaneously preventing these helper
phages from reproducing. V. cholerae therefore uses its PLE to interfere with the ICphage1
reproductive cycle and increase its own virulence. As an evolutionary counterattack, the
ICphage1 contains a CRISPR-Cas system, comprised of two loci and six cas genes, that
actively targets the bacteria’s PLE. A single spacer that targets the PLE is sufficient to
allow the ICphage1 to destroy the PLE and then replicate successfully. It is unclear how
the ICphage1 evolved to have this system, however a comparison with existing characterized
CRISP R systems reveals a high similarity to Type I-F.
6 Discussion
6.1 An example application in biotechnology
The CRISPR system has powerful applications in the molecular biology and genomic edit-
ing fields. In the latter, CRISPR has been used to delete, add, activate or suppress targeted
genes in many species, including human cells, resulting in the so-called “CRISPR craze” [19].
Self-targeting applications, to target and cleave the host chromosome, have been suggested.
These include antimicrobial selection for specific microbial populations within a mixture,
antibiotic resistant gene targeting, and large scale genomic deletion [14, 25]. Targeting of
the uptake of external genetic material to inhibit the spread of resistance genes by HGT
has also been suggested [25]. Here we mention one successful experimental implementation
of using phage-delivered CRISPR-Cas to control antibiotic resistance and horizontal gene
transfer [46]. In this study, temperate lambda phages were used to deliver a CRISPR-Cas
system into E. coli. The locus was programmed to destroy antibiotic resistance-conferring
plasmids and protect against lytic phages. Following its delivery, lytic phages were used to
kill antibiotic-resistant bacteria. The combined result was to leave only antibiotic-sensitive
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bacteria, which could later be killed via antibiotics. This method selected for antibiotic-
sensitized bacteria by creating and delivering to the bacteria a CRISPR-Cas system that
contained spacers which would first self-target the antibiotic-resistance genes and then pro-
tect the bacteria from lytic phages engineered with matching protospacers. It was found that
HGT of antibiotic resistant elements was no longer possible to E. coli containing the system.
Additionally, these antibiotic-sensitive bacteria were resistant to the engineered lytic phages.
Importantly, the construction allowed for the selection of these bacteria and selection against
antibiotic-resistant ones. This bacteria-sensitizing method delivered a CRISPR-Cas system
to phages that then delivered this system to bacteria, which simulated relevant external envi-
ronments such as a hospital fomites or the human skin. An important advantage, therefore,
is that this approach would not require delivery of the CRISPR-Cas system to human host
cells.
6.2 An example application in microbiome modification
Study of the microbiome is a burgeoning field, with implications ranging from health and
disease to learning and mood. The bacterial flora in the gut are heavily influenced by the 15×
greater number of viruses there [47], 90% of which are bacteriophages [48]. A study of the
genetic composition of the phage population in the human gut and their dynamic evolution
in response to environmental perturbations was carried out [44]. Metagenomic sequencing
of the human virome from subjects on a dietary intervention of a high-fat and low fiber, a
low-fat and high fiber, or an ad-lib diet was performed on samples collected over eight days
to understand the structure and dynamics of the phage population. The controlled feeding
regimen caused the virome to change and converge among individual subjects on the same
diet. The sequencing identified many DNA segments responsible for phage functions required
in lytic and lysogenic growth, as well as antibiotic resistance. Interestingly, the study found
phages encoded CRISPR against other phages, as reported in the previous section. CRISPR
arrays in Bacteriodetes from the gut contained spacers matching genetic material from the
virome sequenced in the same individuals, suggesting a functional CRISPR existed.
7 Conclusion
CRISPR-Cas is now a major topic in applied molecular biology and genomic editing. It
first rose to prominence, however, as a novel immune defense mechanism of bacteria against
phages. Theory and modeling have shed light on the dynamics of CRISPR spacer acquisition,
how the diversity of the phage population is reflected in the content of the spacers, and the
potentially complicated patterns of coevolution that bacteria and phages exhibit. CRISPR
puts selection pressure on phages to evolve, selecting for increased rates of substitution and
recombination. The effect that heterogeneous environments have on phage-bacteria coexis-
tence has also been explored. A number of experimental studies have borne out theoretical
predictions regarding phage diversity, mutation and recombination, and heterogeneous en-
vironments. Interestingly, phages also encode strategies to combat the bacterial immune
system, including anti-CRISPR proteins and their own CRISPR-Cas system. Theoretical
wor k and modeling continue to play an integral role in developing a fundamental under-
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standing of the CRISPR-Cas genetic adaptive immune system of prokaryotes and in designing
applications in molecular biotechnology and genomic editing.
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